News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,681 Results
Type
Article (45549)
Company Profile (463)
Press Release (703668)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (217375)
Career Advice (2240)
Deals (37919)
Drug Delivery (109)
Drug Development (85113)
Employer Resources (175)
FDA (16856)
Job Trends (15563)
News (366305)
Policy (34405)
Tag
Academia (2710)
Accelerated approval (11)
Adcomms (27)
Allergies (99)
Alliances (52803)
ALS (115)
Alzheimer's disease (1506)
Antibody-drug conjugate (ADC) (170)
Approvals (16832)
Artificial intelligence (360)
Autoimmune disease (34)
Automation (18)
Bankruptcy (389)
Best Places to Work (11994)
BIOSECURE Act (19)
Biosimilars (125)
Biotechnology (348)
Bladder cancer (98)
Brain cancer (37)
Breast cancer (378)
Cancer (2967)
Cardiovascular disease (231)
Career advice (1879)
Career pathing (32)
CAR-T (196)
CDC (33)
Cell therapy (539)
Cervical cancer (22)
Clinical research (69824)
Collaboration (1078)
Company closure (3)
Compensation (699)
Complete response letters (27)
COVID-19 (2723)
CRISPR (64)
C-suite (343)
Cystic fibrosis (119)
Data (3053)
Decentralized trials (2)
Denatured (31)
Depression (70)
Diabetes (358)
Diagnostics (6639)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (166)
Drug pricing (135)
Drug shortages (30)
Duchenne muscular dystrophy (131)
Earnings (93055)
Editorial (44)
Employer branding (22)
Employer resources (152)
Events (122504)
Executive appointments (886)
FDA (18542)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (980)
Gene editing (143)
Generative AI (29)
Gene therapy (411)
GLP-1 (853)
Government (4679)
Grass and pollen (4)
Guidances (181)
Healthcare (19609)
HIV (44)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (167)
Immuno-oncology (8)
Indications (40)
Infectious disease (2901)
Inflammatory bowel disease (157)
Inflation Reduction Act (13)
Influenza (65)
Intellectual property (122)
Interviews (351)
IPO (17264)
IRA (48)
Job creations (3990)
Job search strategy (1595)
Kidney cancer (13)
Labor market (52)
Layoffs (541)
Leadership (21)
Legal (8506)
Liver cancer (81)
Longevity (12)
Lung cancer (413)
Lymphoma (211)
Machine learning (11)
Management (60)
Manufacturing (411)
MASH (95)
Medical device (13989)
Medtech (13994)
Mergers & acquisitions (21376)
Metabolic disorders (903)
Multiple sclerosis (100)
NASH (20)
Neurodegenerative disease (131)
Neuropsychiatric disorders (40)
Neuroscience (2230)
NextGen: Class of 2025 (6982)
Non-profit (4652)
Now hiring (47)
Obesity (460)
Opinion (252)
Ovarian cancer (103)
Pain (111)
Pancreatic cancer (121)
Parkinson's disease (195)
Partnered (22)
Patents (304)
Patient recruitment (167)
Peanut (52)
People (60996)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21878)
Phase II (30685)
Phase III (22844)
Pipeline (1662)
Policy (212)
Postmarket research (2716)
Preclinical (9416)
Press Release (70)
Prostate cancer (146)
Psychedelics (43)
Radiopharmaceuticals (274)
Rare diseases (497)
Real estate (6312)
Recruiting (67)
Regulatory (23797)
Reports (51)
Research institute (2468)
Resumes & cover letters (380)
Rett syndrome (9)
RNA editing (10)
RSV (50)
Schizophrenia (95)
Series A (168)
Series B (116)
Service/supplier (12)
Sickle cell disease (66)
Special edition (22)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3882)
State (2)
Stomach cancer (15)
Supply chain (78)
Tariffs (57)
The Weekly (58)
Vaccines (817)
Venture capital (56)
Weight loss (290)
Women's health (49)
Worklife (17)
Date
Today (68)
Last 7 days (401)
Last 30 days (1994)
Last 365 days (32911)
2025 (17722)
2024 (36960)
2023 (41488)
2022 (52844)
2021 (57464)
2020 (55763)
2019 (48489)
2018 (36634)
2017 (33860)
2016 (33573)
2015 (39735)
2014 (33928)
2013 (28917)
2012 (31034)
2011 (31753)
2010 (30170)
Location
Africa (805)
Alabama (67)
Alaska (7)
Arizona (259)
Arkansas (14)
Asia (41340)
Australia (6828)
California (7656)
Canada (2380)
China (698)
Colorado (331)
Connecticut (338)
Delaware (199)
Europe (91058)
Florida (1130)
Georgia (249)
Hawaii (1)
Idaho (63)
Illinois (671)
India (28)
Indiana (368)
Iowa (18)
Japan (232)
Kansas (111)
Kentucky (32)
Louisiana (15)
Maine (73)
Maryland (1048)
Massachusetts (5833)
Michigan (269)
Minnesota (470)
Mississippi (3)
Missouri (94)
Montana (31)
Nebraska (25)
Nevada (80)
New Hampshire (72)
New Jersey (2129)
New Mexico (31)
New York (2137)
North Carolina (1165)
North Dakota (10)
Northern California (3334)
Ohio (241)
Oklahoma (16)
Oregon (39)
Pennsylvania (1633)
Puerto Rico (17)
Rhode Island (38)
South America (1201)
South Carolina (35)
South Dakota (1)
Southern California (2845)
Tennessee (128)
Texas (1151)
United States (28571)
Utah (225)
Virginia (193)
Washington D.C. (76)
Washington State (660)
West Virginia (4)
Wisconsin (74)
749,681 Results for "curagen corporation acquired by celldex therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
June 9, 2025
·
5 min read
Press Releases
Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 9, 2025
·
11 min read
Press Releases
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
July 15, 2025
·
13 min read
Press Releases
Celldex Therapeutics to Present at Upcoming March 2025 Investor Conferences
March 5, 2025
·
1 min read
Pharm Country
Celldex Therapeutics to Present at Jefferies 2024 Healthcare Conference
Celldex Therapeutics, Inc. announced that management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 6th at 10:00 am ET.
June 4, 2024
·
1 min read
Business
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 6, 2024
·
11 min read
Press Releases
Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
February 27, 2025
·
12 min read
Press Releases
Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
June 13, 2025
·
10 min read
Press Releases
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 16, 2025
·
8 min read
Press Releases
Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress
June 11, 2025
·
2 min read
1 of 74,969
Next
